Research workbench
Micobacterial Adenosine Kinase in complex with inhibitor
Analyse Micobacterial Adenosine Kinase in complex with inhibitor in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.
- PDB
- 4PVV
- Type
- protein
- Length
- 321 residues
- Chains
- 1
- Method
- x-ray diffraction
- Collection
- MolNFT v2 / PDB Bank
- Contract
- 0xd58B01f6C18086e5202cdC5D7Ad3E41790360102
- Owner
- 0xF4e1AA6f26B7DA48EeAD9B24a97927303eeA07b8
- Resolution
- 2.5
- Source
- Mycobacterium tuberculosis
- Molecule
- Adenosine kinase
- EC
- 2.7.1.20
- UniProt
- P83734
- Ligands
- HO4
- Pockets
- 3 · best druggability 0.65
Structure
x-ray diffraction · resolution 2.5 · 1 distinct chain · 41% helix, 21% strand (DSSP).
| Chain | Molecule | Type | Residues | Secondary structure | UniProt |
|---|---|---|---|---|---|
| A | Adenosine kinase (EC 2.7.1.20) | protein | 321 | 41% helix, 21% strand | P83734 |
Ligands and binding sites
- HO4 · 5-ethynyl-7-(beta-D-ribofuranosyl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine · ligand · chains A
Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.
Pockets
3 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.
| Volume (ų) | Druggability | Buriedness | Lining residues | Inside | |
|---|---|---|---|---|---|
| 1 | 488 | 0.65 | 0.77 | 46 | HO4 |
| 2 | 123 | 0.50 | 0.80 | 22 | empty |
| 3 | 52 | 0.26 | 0.73 | 12 | empty |
Compared structures
- 4PVV · Micobacterial adenosine kinase in complex with inhibitor · the same entry in another collection · chain A against A, TM-score 1.00
Analyse
- Open in the research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides and crosslinks on the 3D structure
- Every structure of UniProt P83734
- Elsewhere: RCSB PDB 4PVV · PDBe 4PVV · UniProt P83734
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.